78 related articles for article (PubMed ID: 25985639)
1. [Breast cancer stem cell research utilizing clinical specimens].
Mukohyama J; Shimono Y
Nihon Rinsho; 2015 May; 73(5):831-5. PubMed ID: 25985639
[TBL] [Abstract][Full Text] [Related]
2. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
4. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
[TBL] [Abstract][Full Text] [Related]
5. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
6. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
8. Distribution of cancer stem cells in ductal invasive carcinoma of breast (review).
Gudadze M; Kankava K; Mariamidze A; Burkadze G
Georgian Med News; 2013 Sep; (222):44-50. PubMed ID: 24099814
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.
Simões BM; Vivanco MD
Future Oncol; 2011 Aug; 7(8):995-1006. PubMed ID: 21823894
[TBL] [Abstract][Full Text] [Related]
12. Involvement of microRNAs in breast cancer.
Adams BD; Guttilla IK; White BA
Semin Reprod Med; 2008 Nov; 26(6):522-36. PubMed ID: 18951334
[TBL] [Abstract][Full Text] [Related]
13. Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells.
Sun X; Qin S; Fan C; Xu C; Du N; Ren H
Oncol Rep; 2013 May; 29(5):2079-87. PubMed ID: 23467929
[TBL] [Abstract][Full Text] [Related]
14. Insights into the cell of origin in breast cancer and breast cancer stem cells.
Lindeman GJ; Visvader JE
Asia Pac J Clin Oncol; 2010 Jun; 6(2):89-97. PubMed ID: 20565420
[TBL] [Abstract][Full Text] [Related]
15. Is ALDH1 a good method for definition of breast cancer stem cells?
Neumeister V; Rimm D
Breast Cancer Res Treat; 2010 Aug; 123(1):109-11. PubMed ID: 19946740
[No Abstract] [Full Text] [Related]
16. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for breast cancer stem cells: the challenges ahead.
Gökmen-Polar Y; Nakshatri H; Badve S
Biomark Med; 2011 Oct; 5(5):661-71. PubMed ID: 22003917
[TBL] [Abstract][Full Text] [Related]
18. Identification of single chain antibodies to breast cancer stem cells using phage display.
Gur D; Liu S; Shukla A; Pero SC; Wicha MS; Krag DN
Biotechnol Prog; 2009; 25(6):1780-7. PubMed ID: 19899107
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Resetkova E; Reis-Filho JS; Jain RK; Mehta R; Thorat MA; Nakshatri H; Badve S
Breast Cancer Res Treat; 2010 Aug; 123(1):97-108. PubMed ID: 19911270
[TBL] [Abstract][Full Text] [Related]
20. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells.
Nishikata T; Ishikawa M; Matsuyama T; Takamatsu K; Fukuhara T; Konishi Y
Anticancer Res; 2013 Jul; 33(7):2867-73. PubMed ID: 23780972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
